J Res Med Sci
The most recent articles from:
J Res Med Sci
-
To compare the efficacy of subconjunctival administration of bevacizumab and different doses of sunitinib malate in reducing corneal neovascularization (CNV). ⋯ Subconjunctival sunitinib malate is more effective than bevacizumab in regressing CNV. This effect is more prominent on day 14.
-
[This corrects the article on p. 107 in vol. 21, PMID: 28250784.].